Form 4: Rocket Pharmaceuticals CEO Sells Shares to Cover Tax Obligations

Gaurav Shah, CEO of Rocket Pharmaceuticals, sold 16,303 shares of common stock to cover tax withholding obligations related to the vesting of Restricted Stock Units (RSUs).

Summary

• Gaurav Shah, the CEO of Rocket Pharmaceuticals, sold 16,303 shares of common stock on February 21, 2025, at a price of $10.58 per share.
• The sale was executed to cover tax withholding obligations associated with the vesting of Restricted Stock Units (RSUs).
• Following the transaction, Shah directly owns 772,680 shares of common stock.
• Shah also indirectly owns 207,897 shares through his spouse and 198,341 shares through the Gaurav D. Shah Irrevocable Trust.

Sentiment

Score: 6

Explanation: The sentiment is neutral as the transaction is a routine sale of shares to cover tax obligations, which is a common practice among executives.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for them to sell a portion of their shares to cover the taxes associated with the vesting of RSUs or stock options. It does not necessarily indicate a lack of confidence in the company.

Stakeholder Impact

• The sale of shares by the CEO could have a minor negative impact on shareholder sentiment, but it is unlikely to be significant given the reason for the sale.

Key Dates